AAAAAA
Results: 1-25/26
Authors:
Dale, J
Daykin, J
Holder, R
Sheppard, MC
Franklyn, JA
Citation: J. Dale et al., Weight gain following treatment of hyperthyroidism, CLIN ENDOCR, 55(2), 2001, pp. 233-239
Authors:
Kumar, H
Daykin, J
Holder, R
Watkinson, JC
Sheppard, MC
Franklyn, JA
Citation: H. Kumar et al., An audit of management of differentiated thyroid cancer in specialist and non-specialist clinic settings, CLIN ENDOCR, 54(6), 2001, pp. 719-723
Authors:
Osman, F
Ayuk, J
Dale, J
Franklyn, JA
Gammage, MD
Citation: F. Osman et al., Thyrotoxicosis with heart block, J ROY S MED, 94(7), 2001, pp. 346-348
Authors:
Allahabadia, A
Heward, JM
Nithiyananthan, R
Gibson, SM
Reuser, TTQ
Dodson, PM
Franklyn, JA
Gough, SCL
Citation: A. Allahabadia et al., MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease, LANCET, 358(9286), 2001, pp. 984-985
Authors:
Parle, JV
Maisonneuve, P
Sheppard, MC
Boyle, P
Franklyn, JA
Citation: Jv. Parle et al., Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study, LANCET, 358(9285), 2001, pp. 861-865
Authors:
Allahabadia, A
Daykin, J
Sheppard, MC
Gough, SCL
Franklyn, JA
Citation: A. Allahabadia et al., Radioiodine treatment of hyperthyroidism - Prognostic factors for outcome, J CLIN END, 86(8), 2001, pp. 3611-3617
Authors:
Heward, JM
Nithiyananthan, R
Allahabadia, A
Gibson, S
Franklyn, JA
Gough, SCL
Citation: Jm. Heward et al., No association of an interleukin 4 gene promoter polymorphism with Graves'disease in the United Kingdom, J CLIN END, 86(8), 2001, pp. 3861-3863
Authors:
Franklyn, JA
Citation: Ja. Franklyn, Thyroid hormones and antithyroid drugs, SIDE EFFECT, 23, 2000, pp. 451-453
Authors:
Kilby, MD
Gittoes, N
McCabe, C
Verhaeg, J
Franklyn, JA
Citation: Md. Kilby et al., Expression of thyroid receptor isoforms in the human fetal central nervoussystem and the effects of intrauterine growth restriction, CLIN ENDOCR, 53(4), 2000, pp. 469-477
Authors:
Franklyn, JA
Citation: Ja. Franklyn, Lack of consensus in Europe in the management of nontoxic multinodular goitre, CLIN ENDOCR, 53(1), 2000, pp. 3-4
Authors:
Bishop, CM
McCabe, CJ
Gittoes, NJL
Butler, PJ
Franklyn, JA
Citation: Cm. Bishop et al., Tissue-specific regulation of thyroid hormone receptor mRNA isoforms and target gene proteins in domestic ducks, J ENDOCR, 165(3), 2000, pp. 607-615
Authors:
Allahabadia, A
Daykin, J
Holder, RL
Sheppard, MC
Gough, SCL
Franklyn, JA
Citation: A. Allahabadia et al., Age and gender predict the outcome of treatment for Graves' hyperthyroidism, J CLIN END, 85(3), 2000, pp. 1038-1042
Authors:
Nithiyananthan, R
Heward, JM
Allahabadia, A
Barnett, AH
Franklyn, JA
Gough, SCL
Citation: R. Nithiyananthan et al., A heterozygous deletion of the autoimmune regulator (AIRE1) gene, autoimmune thyroid disease, and type 1 diabetes: No evidence for association, J CLIN END, 85(3), 2000, pp. 1320-1322
Authors:
Heward, J
Allahabadia, A
Gordon, C
Sheppard, MC
Barnett, AH
Franklyn, JA
Gough, SCL
Citation: J. Heward et al., The interleukin-1 receptor antagonist gene shows no allelic association with three autoimmune diseases, THYROID, 9(6), 1999, pp. 627-628
Authors:
Allahabadia, A
Heward, J
Carr-Smith, J
Daykin, J
Barnett, AH
Sheppard, MC
Franklyn, JA
Gough, SCL
Citation: A. Allahabadia et al., Sharing of susceptibility loci between autoimmune diseases: Lack of association of the insulin gene region with Graves' disease, THYROID, 9(3), 1999, pp. 317-318
Authors:
Kumar, H
Daykin, J
Holder, R
Watkinson, JC
Sheppard, MC
Franklyn, JA
Citation: H. Kumar et al., Gender, clinical findings, and serum thyrotropin measurements in the prediction of thyroid neoplasia in 1005 patients presenting with thyroid enlargement and investigated by fine-needle aspiration cytology, THYROID, 9(11), 1999, pp. 1105-1109
Authors:
Heward, JM
Allahabadia, A
Sheppard, MC
Barnett, AH
Franklyn, JA
Gough, SCL
Citation: Jm. Heward et al., Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB10304-DQB1*O2-DQA1*0501, CLIN ENDOCR, 51(1), 1999, pp. 115-118
Authors:
McCabe, CJ
Gittoes, NJL
Sheppard, MC
Franklyn, JA
Citation: Cj. Mccabe et al., Increased MEN1 mRNA expression in sporadic pituitary tumours, CLIN ENDOCR, 50(6), 1999, pp. 727-733
Authors:
Kumar, H
Daykin, J
Betteridge, J
Holder, R
Sheppard, MC
Franklyn, JA
Citation: H. Kumar et al., Prevalence and clinical usefulness of thyroid antibodies in different disease states of the thyroid, CLIN ENDOCR, 50(5), 1999, pp. 679-680
Authors:
Bradley, MD
Olliff, JFC
Winer, JB
Franklyn, JA
Citation: Md. Bradley et al., An unusual cause of hyponatraemia, CLIN ENDOCR, 50(5), 1999, pp. 680-682
Authors:
Franklyn, JA
Maisonneuve, P
Sheppard, M
Betteridge, J
Boyle, P
Citation: Ja. Franklyn et al., Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study, LANCET, 353(9170), 1999, pp. 2111-2115
Authors:
Franklyn, JA
Citation: Ja. Franklyn, Thyroid disease and its treatment: short- and long-term consequences, J ROY COL P, 33(6), 1999, pp. 564-567
Authors:
Heward, JM
Allahabadia, A
Armitage, M
Hattersley, A
Dodson, PM
MacLeod, K
Carr-Smith, J
Daykin, J
Daly, A
Sheppard, MC
Holder, RL
Barnett, AH
Franklyn, JA
Gough, SCL
Citation: Jm. Heward et al., The development of Graves' disease and the CTLA-4 gene on chromosome 2q33, J CLIN END, 84(7), 1999, pp. 2398-2401
Authors:
McCabe, CJ
Gittoes, NJ
Sheppard, MC
Franklyn, JA
Citation: Cj. Mccabe et al., Thyroid receptor alpha 1 and alpha 2 mutations in nonfunctioning pituitarytumors, J CLIN END, 84(2), 1999, pp. 649-653
Authors:
Heward, J
Gordon, C
Allahabadia, A
Barnett, AH
Franklyn, JA
Gough, SCL
Citation: J. Heward et al., The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus, ANN RHEUM D, 58(3), 1999, pp. 193-195